Variant report

Variant	nsv880020
Chromosome Location	chr4:133187185-133461762
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr4:133266134-133266306	K562	blood:	n/a	n/a
2	ATF2	chr4:133416334-133416868	H1-hESC	embryonic stem cell:	n/a	n/a
3	ATF2	chr4:133416260-133417117	H1-hESC	embryonic stem cell:	n/a	n/a
4	BACH1	chr4:133367293-133367347	K562	blood:	n/a	n/a
5	BCL11A	chr4:133416681-133416977	H1-hESC	embryonic stem cell:	n/a	n/a
6	BHLHE40	chr4:133265695-133265813	K562	blood:	n/a	n/a
7	BHLHE40	chr4:133264871-133264883	K562	blood:	n/a	n/a
8	BHLHE40	chr4:133266102-133266846	K562	blood:	n/a	n/a
9	BRCA1	chr4:133266159-133266384	Hela-S3	cervix:	n/a	n/a
10	CBX3	chr4:133338441-133338670	HCT-116	colon:	n/a	n/a
11	CBX3	chr4:133265310-133265941	K562	blood:	n/a	n/a
12	CBX3	chr4:133266054-133266694	K562	blood:	n/a	n/a
13	CCNT2	chr4:133266111-133266381	K562	blood:	n/a	n/a
14	CEBPB	chr4:133294679-133295027	HepG2	liver:	n/a	n/a
15	CEBPB	chr4:133228257-133228566	HepG2	liver:	n/a	chr4:133228409-133228420
16	CEBPB	chr4:133363937-133364232	K562	blood:	n/a	chr4:133364078-133364089 chr4:133364031-133364042
17	CEBPB	chr4:133408492-133408827	HepG2	liver:	n/a	chr4:133408637-133408648
18	CEBPB	chr4:133441568-133441915	IMR90	lung:	n/a	n/a
19	CEBPB	chr4:133441571-133441918	A549	lung:	n/a	n/a
20	CEBPB	chr4:133234404-133234637	HepG2	liver:	n/a	n/a
21	CEBPB	chr4:133427760-133428011	HepG2	liver:	n/a	chr4:133427871-133427882 chr4:133427870-133427883 chr4:133427870-133427883 chr4:133427870-133427881 chr4:133427870-133427881
22	CEBPB	chr4:133363913-133364226	IMR90	lung:	n/a	chr4:133364078-133364089 chr4:133364031-133364042
23	CEBPB	chr4:133318436-133318624	HepG2	liver:	n/a	chr4:133318505-133318516 chr4:133318505-133318518 chr4:133318507-133318518
24	CEBPB	chr4:133254850-133255208	Hela-S3	cervix:	n/a	n/a
25	CEBPB	chr4:133408509-133408832	K562	blood:	n/a	chr4:133408637-133408648
26	CEBPB	chr4:133310833-133311100	HepG2	liver:	n/a	chr4:133310930-133310941
27	CEBPB	chr4:133240140-133240393	HepG2	liver:	n/a	chr4:133240209-133240220 chr4:133240188-133240199 chr4:133240209-133240222
28	CEBPB	chr4:133223604-133223874	HepG2	liver:	n/a	chr4:133223742-133223753 chr4:133223743-133223754 chr4:133223742-133223755
29	CEBPB	chr4:133278703-133278936	ECC-1	luminal epithelium:	n/a	chr4:133278842-133278859
30	CEBPB	chr4:133234378-133234608	A549	lung:	n/a	n/a
31	CEBPB	chr4:133234391-133234624	IMR90	lung:	n/a	n/a
32	CEBPB	chr4:133408526-133408826	ECC-1	luminal epithelium:	n/a	chr4:133408637-133408648
33	CEBPB	chr4:133363956-133364215	HepG2	liver:	n/a	chr4:133364078-133364089 chr4:133364031-133364042
34	CEBPB	chr4:133310830-133311107	IMR90	lung:	n/a	chr4:133310930-133310941
35	CEBPB	chr4:133223702-133223847	H1-hESC	embryonic stem cell:	n/a	chr4:133223742-133223753 chr4:133223743-133223754 chr4:133223742-133223755
36	CEBPB	chr4:133266193-133266232	K562	blood:	n/a	n/a
37	CEBPB	chr4:133408491-133408784	MCF-7	breast:	n/a	chr4:133408637-133408648
38	CEBPB	chr4:133304647-133305173	Hela-S3	cervix:	n/a	n/a
39	CEBPB	chr4:133240074-133240372	K562	blood:	n/a	chr4:133240209-133240220 chr4:133240188-133240199 chr4:133240209-133240222
40	CEBPB	chr4:133294679-133294861	H1-hESC	embryonic stem cell:	n/a	n/a
41	CEBPB	chr4:133440969-133441202	HepG2	liver:	n/a	chr4:133441077-133441088
42	CEBPB	chr4:133294688-133295002	A549	lung:	n/a	n/a
43	CEBPB	chr4:133254553-133255549	IMR90	lung:	n/a	chr4:133254713-133254724 chr4:133254713-133254726
44	CEBPB	chr4:133441707-133441832	K562	blood:	n/a	n/a
45	CEBPB	chr4:133246117-133246325	HepG2	liver:	n/a	chr4:133246262-133246273 chr4:133246273-133246286 chr4:133246273-133246284
46	CEBPB	chr4:133330797-133331127	HepG2	liver:	n/a	chr4:133330971-133330982
47	CEBPB	chr4:133441581-133441924	HepG2	liver:	n/a	n/a
48	CEBPB	chr4:133240156-133240388	A549	lung:	n/a	chr4:133240209-133240220 chr4:133240188-133240199 chr4:133240209-133240222
49	CEBPB	chr4:133363932-133364193	H1-hESC	embryonic stem cell:	n/a	chr4:133364078-133364089 chr4:133364031-133364042
50	CEBPB	chr4:133408488-133408714	Hela-S3	cervix:	n/a	chr4:133408637-133408648

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr4:133266193-133266243	AG10803	skin:	n/a
2	chr4:133266322-133266372	HAEpiC	amniotic membrane:	n/a
3	chr4:133266193-133266243	Jurkat	blood:	n/a
4	chr4:133266322-133266372	AG04450	lung:	fetal
5	chr4:133266193-133266243	SKMC	muscle:	n/a
6	chr4:133266322-133266372	HepG2	liver:	n/a
7	chr4:133266322-133266372	SK-N-SH_RA	brain:	n/a
8	chr4:133266322-133266372	NB4	blood:	n/a
9	chr4:133266322-133266372	AG10803	skin:	n/a
10	chr4:133266322-133266372	Hepatocyte	liver:	n/a
11	chr4:133266322-133266372	HCM	heart:	n/a
12	chr4:133266322-133266372	PrEC	prostate:	n/a
13	chr4:133266322-133266372	Jurkat	blood:	n/a
14	chr4:133266193-133266243	HRPEpiC	eye:	n/a
15	chr4:133266193-133266243	AoSMC	blood vessel:	n/a
16	chr4:133266193-133266243	AG04449	skin:	fetal
17	chr4:133266322-133266372	SKMC	muscle:	n/a
18	chr4:133266322-133266372	Caco-2	colon:	n/a
19	chr4:133266193-133266243	HUVEC	blood vessel:	n/a
20	chr4:133266322-133266372	HCT-116	colon:	n/a
21	chr4:133266322-133266372	HRE	kidney:	n/a
22	chr4:133266193-133266243	Hela-S3	cervix:	n/a
23	chr4:133266193-133266243	HEK293	kidney:	embryo
24	chr4:133266193-133266243	BE2_C	brain:	n/a
25	chr4:133266322-133266372	BJ	skin:	n/a
26	chr4:133266322-133266372	NHDF-neo	bronchial:	n/a
27	chr4:133266193-133266243	LNCaP	prostate:	n/a
28	chr4:133266193-133266243	HL-60	blood:	n/a
29	chr4:133266193-133266243	H1-hESC	embryonic stem cell:	embryo
30	chr4:133266322-133266372	GM06990	blood:	n/a
31	chr4:133266193-133266243	T-47D	breast:	n/a
32	chr4:133266322-133266372	PANC-1	pancreas:	n/a
33	chr4:133266193-133266243	MCF10A-Er-Src	breast:	n/a
34	chr4:133266193-133266243	PFSK-1	brain:	n/a
35	chr4:133266322-133266372	MCF10A-Er-Src	breast:	n/a
36	chr4:133266322-133266372	AG04449	skin:	fetal
37	chr4:133266322-133266372	ECC-1	luminal epithelium:	n/a
38	chr4:133266193-133266243	AG09309	skin:	n/a
39	chr4:133266322-133266372	HRCEpiC	kidney:	n/a
40	chr4:133266322-133266372	HPAEpiC	pulmonary alveolar:	n/a
41	chr4:133266193-133266243	U87	brain:	n/a
42	chr4:133266322-133266372	BE2_C	brain:	n/a
43	chr4:133266322-133266372	CMK	blood:	n/a
44	chr4:133266322-133266372	IMR90	lung:	fetal
45	chr4:133266193-133266243	RPTEC	kidney:	n/a
46	chr4:133266322-133266372	LNCaP	prostate:	n/a
47	chr4:133266193-133266243	HIPEpiC	eye:	n/a
48	chr4:133266322-133266372	NH-A	brain:	n/a
49	chr4:133266322-133266372	GM12878	blood:	n/a
50	chr4:133266193-133266243	A549	lung:	n/a

No.	Distal block	Cell Line	Cell type
1	chr4:133337477..133339790-chr4:133339994..133342745,2	K562	blood:
2	chr4:133352255..133354798-chr4:133356746..133359488,2	K562	blood:
3	chr4:133265507..133268108-chr4:133268991..133271558,3	K562	blood:
4	chr4:133254539..133258188-chr4:133265340..133266888,3	K562	blood:
5	chr4:133337477..133339790-chr4:133339994..133342745,2	K562	blood:
6	chr4:133346218..133346845-chr6:148869148..148869834,2	MCF-7	breast:
7	chr4:133254539..133258188-chr4:133265340..133266888,3	K562	blood:
8	chr4:133263144..133265552-chr4:133295032..133296835,2	K562	blood:
9	chr4:133265507..133268108-chr4:133268991..133271558,3	K562	blood:
10	chr4:102842819..102843467-chr4:133460108..133460904,2	MCF-7	breast:
11	chr4:133246638..133249812-chr4:133265864..133268563,3	K562	blood:
12	chr4:133264521..133268108-chr4:133268991..133272057,6	K562	blood:
13	chr4:133246638..133249812-chr4:133265864..133268563,3	K562	blood:
14	chr4:133294490..133296244-chr4:133317464..133320179,2	K562	blood:
15	chr4:133264521..133268108-chr4:133268991..133272057,6	K562	blood:
16	chr4:133263144..133265552-chr4:133295032..133296835,2	K562	blood:
17	chr4:133294490..133296244-chr4:133317464..133320179,2	K562	blood:
18	chr4:133116257..133118225-chr4:133445549..133447464,2	MCF-7	breast:
19	chr4:133352255..133354798-chr4:133356746..133359488,2	K562	blood:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-PCDH10-2	chr4:133452275-133452325	XLOC_003691
2	lnc-RP11-62N21.1.1-11	chr4:133288941-133289634	NONHSAT098333

Variant related genes	Relation type
ELL2P2	TF binding region
ENSG00000248369	TF binding region
ELL2P2	CpG island
ENSG00000248369	CpG island
OSBP	miRNA target sites

Extended variants
information (count: 3805 )
Associated
traits (count: 79 )

Variant overlapped rSNPs/rCNVs (count:3805 , 50 per page) page: 1 2 3 4 5 6 7 ... 77

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs1039270	chr4:133187185-133187186	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs182544116	chr4:133187197-133187198	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs546144929	chr4:133187201-133187202	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs186509428	chr4:133187244-133187245	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs532059997	chr4:133187302-133187303	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs144064629	chr4:133187307-133187308	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs562274850	chr4:133187309-133187310	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs189779780	chr4:133187380-133187381	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs1039269	chr4:133187461-133187462	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
10	rs139894405	chr4:133187474-133187475	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs553566195	chr4:133187534-133187535	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs538337311	chr4:133187541-133187542	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs573436927	chr4:133187545-133187546	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs552176460	chr4:133187673-133187674	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs368995486	chr4:133187780-133187781	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs372950410	chr4:133187782-133187783	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs398108014	chr4:133187793-133187794	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs538182264	chr4:133187800-133187801	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs142483433	chr4:133187834-133187835	Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs555468275	chr4:133187837-133187838	Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs188691282	chr4:133187882-133187883	Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs193287597	chr4:133187904-133187905	Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs553865573	chr4:133187925-133187926	Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs577303064	chr4:133187962-133187963	Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs552147957	chr4:133187972-133187973	Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs545960267	chr4:133188044-133188045	Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs185130407	chr4:133188062-133188063	Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs528050855	chr4:133188073-133188074	Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs143494256	chr4:133188096-133188097	Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs575718410	chr4:133188112-133188113	Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs562341442	chr4:133188135-133188136	Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs527900379	chr4:133188155-133188156	Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs544669254	chr4:133188182-133188183	Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs548042277	chr4:133188235-133188236	Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs188841728	chr4:133188272-133188273	Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs111917074	chr4:133188310-133188311	Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs551978993	chr4:133188312-133188313	Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs78087817	chr4:133188394-133188395	Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs368808531	chr4:133188446-133188447	Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs531164878	chr4:133188457-133188458	Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs551672221	chr4:133188465-133188466	Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs528959044	chr4:133188467-133188468	Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs567980462	chr4:133188478-133188479	Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs371949272	chr4:133188510-133188511	Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs533821289	chr4:133188530-133188531	Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs141266235	chr4:133188543-133188544	Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs570552424	chr4:133188587-133188588	Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs539930290	chr4:133188630-133188631	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs6841162	chr4:133188640-133188641	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
50	rs576405686	chr4:133188694-133188695	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:79)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Medulloblastoma	21979893	CNVD
Neuroblastoma	18923191	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Breast cancer	21858162	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Gastric cancer	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	17603634	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Breast cancer	16272173	CNVD
Colorectal cancer	19359472	CNVD
Malignant mesothelioma	18160781	CNVD
Medulloblastoma	18056178	CNVD
Multiple myeloma	17077331	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Oral squamous cell carcinoma	17134496	CNVD
4q-syndrome	17576883	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Muscular dystrophy	21149563	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Cervical cancer	21062161	CNVD
Metanephric adenoma	20802469	CNVD
Breast cancer	16608533	CNVD
Lung cancer	19208797	CNVD
Wilms tumour	21544195	CNVD
Breast cancer	21785460	CNVD
Lung cancer	18438408	CNVD
Cancer	22429812	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	21183584	CNVD
primary effusion lymphomas	17116491	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Breast cancer	17133270	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Congenital anomalies of the kidney and urinary tract	20505237	CNVD
Breast cancer	17393978	CNVD
Esophageal cancer	21851588	CNVD
Colorectal cancer	16272173	CNVD
Testicular germ cell tumor	18059402	CNVD
Ovarian cancer	22174824	CNVD
Neuroblastoma	21899760	CNVD
Renal cell carcinoma	18194544	CNVD
Olfactory neuroblastoma	18408657	CNVD
Hepatocellular carcinoma	16750200	CNVD
Acute myeloid leukemia	16864856	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Hodgkin''s lymphoma	17606441	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Colorectal cancer	20459617	CNVD
Lung squamous cell carcinoma	22363434	CNVD
Mental retardation	17847001	CNVD
Myelofibrosis	22110671	CNVD
Autism	18923514	CNVD
Autism	22241247	CNVD
Mental retardation	17901693	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
small cell lung cancer	20016488	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Non-syndromic sensorineural hearing loss	19587683	CNVD

Chromatin state (count:219 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:133184000-133190000	Enhancers	Dnd41	blood
2	chr4:133185600-133187600	Weak transcription	Fetal Lung	lung
3	chr4:133185600-133187800	Weak transcription	Fetal Thymus	thymus
4	chr4:133187400-133188600	Enhancers	Primary T cells from cord blood	blood
5	chr4:133187600-133188000	Enhancers	Fetal Lung	lung
6	chr4:133187600-133188400	Enhancers	Primary B cells from cord blood	blood
7	chr4:133187800-133188600	Enhancers	Fetal Thymus	thymus
8	chr4:133188200-133188800	Enhancers	Thymus	Thymus
9	chr4:133188600-133190000	Weak transcription	Fetal Thymus	thymus
10	chr4:133190000-133190400	Weak transcription	Dnd41	blood
11	chr4:133190000-133190800	ZNF genes & repeats	Fetal Thymus	thymus
12	chr4:133190400-133191000	ZNF genes & repeats	Dnd41	blood
13	chr4:133190600-133190800	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
14	chr4:133190600-133191000	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
15	chr4:133200000-133200400	Weak transcription	H9 Cell Line	embryonic stem cell
16	chr4:133201200-133201600	ZNF genes & repeats	ES-UCSF4 Cell Line	embryonic stem cell
17	chr4:133201600-133205600	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
18	chr4:133204200-133204600	Enhancers	HUES48 Cell Line	embryonic stem cell
19	chr4:133204200-133204600	Enhancers	iPS-15b Cell Line	embryonic stem cell
20	chr4:133204600-133205800	Weak transcription	iPS-15b Cell Line	embryonic stem cell
21	chr4:133205600-133206400	ZNF genes & repeats	ES-UCSF4 Cell Line	embryonic stem cell
22	chr4:133205600-133207400	ZNF genes & repeats	Dnd41	blood
23	chr4:133205800-133206000	ZNF genes & repeats	iPS-15b Cell Line	embryonic stem cell
24	chr4:133205800-133206200	ZNF genes & repeats	HUES64 Cell Line	embryonic stem cell
25	chr4:133217600-133218200	Active TSS	Primary B cells from cord blood	blood
26	chr4:133217600-133219200	Enhancers	Fetal Lung	lung
27	chr4:133217800-133218200	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
28	chr4:133218200-133218800	Weak transcription	Primary B cells from cord blood	blood
29	chr4:133218200-133221000	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
30	chr4:133218400-133218800	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
31	chr4:133218400-133219000	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
32	chr4:133218800-133219600	Enhancers	Primary B cells from cord blood	blood
33	chr4:133219200-133220600	Weak transcription	Fetal Lung	lung
34	chr4:133220600-133221600	Enhancers	Fetal Lung	lung
35	chr4:133221000-133221400	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
36	chr4:133221600-133222400	Weak transcription	Fetal Lung	lung
37	chr4:133222400-133222600	Enhancers	Fetal Lung	lung
38	chr4:133222600-133224800	Weak transcription	Fetal Lung	lung
39	chr4:133224800-133225000	Enhancers	Fetal Lung	lung
40	chr4:133234400-133235400	Enhancers	Fetal Adrenal Gland	Adrenal Gland
41	chr4:133235000-133235400	Enhancers	Brain Anterior Caudate	brain
42	chr4:133236800-133237000	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
43	chr4:133237000-133237200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
44	chr4:133242200-133242400	Enhancers	H9 Cell Line	embryonic stem cell
45	chr4:133254000-133255200	Enhancers	NHLF	lung
46	chr4:133254400-133255600	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
47	chr4:133254800-133255600	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
48	chr4:133254800-133255600	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
49	chr4:133265000-133265200	Enhancers	Hela-S3	cervix
50	chr4:133265200-133265400	Enhancers	Placenta	Placenta

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links